Skip To Main Content
Mengyin Cai on Muck Rack

Mengyin Cai

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mengyin

Contact Mengyin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety and efficacy of human gingiva-derived mesenchymal stem cells in patients with type 1 diabetes: a double-blind, randomized, placebo-controlled, phase 1 trial

|
By Qi Tang, Li Zhou Verified, Liwen Fan, Wei Zhang, Xixiang Tang, Mei Li, Yanhua Zhu, Jia Yuan, Zheng Chen, Song Zheng, Yanming Chen, Donglan Zeng, Mengyin Cai
| Nature Verified
Abstract Current therapies for type 1 diabetes mellitus (T1DM) rarely halt progressive β-cell function loss due to autoimmune attack. Human gingiva-derived mesenchymal stem cells (GMSCs) have been shown to have therapeutic effects on a variety of autoimmune diseases through their potent immunomodulatory capacity, but clinical evidence for these effects is lacking in patients with T1DM.
Open in Who Shared Issue with article?
See all 1 articles